|
|
 |
|
Viewing report
|
|
|
|
Innovations in Wound Care Devices and Dressings
Business Insights, Nov 2011, Pages: 114
Wound care is diverse and complex; the broad range of sizes, shapes, stages, and types of wounds has created the need for a wide variety of products. The advent of growth factors, semi-synthetic human skin, and negative-pressure wound therapy has stimulated growth over the last decade. The key unmet need in wound care is adequate management of chronic wounds.
Features and benefits:
- Identify and understand new developments and innovations in the medical device segment of the wound healing industry.
- Understand key challenges and opportunities in this segment, including the threat from biologics and pharmaceutically active wound care.
- Identify new market entrants and understand the opportunities they may present and potential impact they may have.
- Understand the limitations of the pipeline wound care innovations and identify continuing unmet needs in the wound care sector.
- Gain insight into the most likely future directions of wound care technologies.
Highlights:
- Key unmet needs in the wound healing medical device segment are the need for more compelling clinical evidence, an ability to compete with dressings on cost, and improved patient convenience. The use of electrical stimulation for wound care has been taken up slowly, but a range of new portable devices are driving innovation in this area.
- Oxygen therapy has traditionally involved the use of hyperbaric oxygen chambers or cumbersome devices. A range of new compact devices is driving innovation in this market. Another area of development is within the diagnostic market, where there are several pre-market employing different modes of action to deliver point-of-care wound diagnostics.
- Significant areas of development in the advanced wound dressing segment are within the areas of antimicrobials (silver, iodine, and honey) hydrocolloids and hydrogels. The medical device and advanced wound dressing market will be increasingly affected by biologics and crossover products are expected to appear as these segments of the market merge.
Your key questions answered:
- What are the key innovations making an impact on the state of the art in wound care devices and dressings?
- Who are the key players developing these innovations?
- What are the implications of the new technologies for the wound care market, and how will the future landscape change as a result?
- What is the clinical evidence that has been gathered in support of efficacy, and what remains to be proven for a compelling case to be established?
- What threat is posed by recent developments in biologics and pharmacetutically active wound care?
|
|
|
|
